Valeant Pharmaceuticals International (VRX) Fell To A 3-Month Low

Wells Fargo initiated coverage on shares of Valeant Pharmaceuticals International (VRX) Monday morning with an "Underperform" rating.

from RTT - Before the Bell http://ift.tt/1XKalwx
via IFTTT